Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.

[1]  E. Pascali,et al.  Monoclonal Bence Jones proteinuria in chronic lymphocytic leukaemia. , 2009, Scandinavian journal of haematology.

[2]  T. Therneau,et al.  Immunoglobulin free light chains and solitary plasmacytoma of bone. , 2006, Blood.

[3]  S. Vincent Rajkumar,et al.  Monoclonal gammopathy of undetermined significance , 2013, Radiopaedia.org.

[4]  S. Ansell,et al.  Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. , 2006, Blood.

[5]  T. Therneau,et al.  Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. , 2005, Blood.

[6]  A. Dispenzieri,et al.  Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. , 2005, Clinical chemistry.

[7]  Yuhai Tu,et al.  Identification of a global gene expression signature of B-chronic lymphocytic leukemia. , 2003, Molecular cancer research : MCR.

[8]  J. Katzmann,et al.  Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. , 2003, American journal of clinical pathology.

[9]  J. Katzmann,et al.  Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains , 2002 .

[10]  T. Larson,et al.  Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma. , 2002, Clinical chemistry.

[11]  Terry M Therneau,et al.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.

[12]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[13]  A. Tefferi,et al.  Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemia , 2001, British journal of haematology.

[14]  M. Drayson,et al.  Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. , 2001, Blood.

[15]  M. Drayson,et al.  Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. , 2001, Clinical chemistry.

[16]  C. Bloomfield,et al.  The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 , 2000, Modern Pathology.

[17]  K. Rajewsky,et al.  Cellular origin of human B-cell lymphomas. , 1999, The New England journal of medicine.

[18]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[19]  R. Kyle,et al.  Monoclonal Gammopathy of Undetermined Significance , 1994, Annals of Internal Medicine.

[20]  B. Dreyfus,et al.  High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia. , 1994, Blood.

[21]  E. Pascali,et al.  The clinical spectrum of pure bence jones proteinuria: A study of 66 patients , 1988, Cancer.

[22]  J. Diebold,et al.  THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES REPORT OF THE CLINICAL ADVISORY COMMITTEE MEETING , 2000 .

[23]  E. Pascali,et al.  Serum and urine monoclonal immunoglobulins in malignant non-Hodgkin's lymphoma. , 1986, Acta haematologica.

[24]  R. Alexanian.  Monoclonal gammopathy in lymphoma. , 1975, Archives of internal medicine.